In This Section

ACE2: From Discovery to the Heart of a Pandemic

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

Date:
Apr 8, 2021 ‐ 11:00 am
End Date/Time-NEW
Location - People View

The CCMT Lecture Series 2020-2021, sponsored The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, presents:

ACE2: From Discovery to the Heart of a Pandemic

Speaker: Josef Penninger, MD

Director, Life Sciences Institute and Professor, Department of Medicine Genetics, University of British Columbia

Description of Research:

Josef Martin Penninger, MD, born in Gurten, Austria, is a world-renowned geneticist and the Canada 150 Research Chair in Functional Genetics. His major accomplishments include pioneering insights into the molecular basis of osteoporosis and breast cancer, demonstrating a critical role for ACE2 as the cellular receptor for the SARS Coronavirus infections, and linking ACE2 to lung failure in such infections. He has published extensively in several multidisciplinary scientific journals, with more than 60 publications in Cell, Nature, and Science. Dr. Penninger has received numerous awards including the Wittgenstein Prize of the Austrian Federal Government, the Descartes Prize for Research, the Ernst Jung Prize for Medical Excellence, the Innovator Award from the U.S. Department of Defense, and the Austrian Cross of Honor for Science and Art First Class.

Host: Yuanquan Song, PhD
Please e-mail songy2@chop.edu if you would like to meet with the speaker.

Add to Calendar 2021-04-08 11:00:00 2021-04-08 12:00:00 ACE2: From Discovery to the Heart of a Pandemic The CCMT Lecture Series 2020-2021, sponsored The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, presents: ACE2: From Discovery to the Heart of a Pandemic Speaker: Josef Penninger, MD Director, Life Sciences Institute and Professor, Department of Medicine Genetics, University of British Columbia Description of Research: Josef Martin Penninger, MD, born in Gurten, Austria, is a world-renowned geneticist and the Canada 150 Research Chair in Functional Genetics. His major accomplishments include pioneering insights into the molecular basis of osteoporosis and breast cancer, demonstrating a critical role for ACE2 as the cellular receptor for the SARS Coronavirus infections, and linking ACE2 to lung failure in such infections. He has published extensively in several multidisciplinary scientific journals, with more than 60 publications in Cell, Nature, and Science. Dr. Penninger has received numerous awards including the Wittgenstein Prize of the Austrian Federal Government, the Descartes Prize for Research, the Ernst Jung Prize for Medical Excellence, the Innovator Award from the U.S. Department of Defense, and the Austrian Cross of Honor for Science and Art First Class. Host: Yuanquan Song, PhD Please e-mail songy2@chop.edu if you would like to meet with the speaker. - Raymond G. Perelman Center for Cellular and Molecular Therapeutics songy2@chop.edu America/New_York public
Audience: